{
  "ticker": "AFI",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973352",
  "id": "02973352",
  "pages": 27,
  "price_sensitive": false,
  "date": "20250728",
  "time": "1429",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m6sbc2bjt1xn.pdf",
  "summary": "**Full Year Results Summary (Material Information Only)**  \n\n- **Financial Performance:**  \n  - Final dividend: **12 cents per share** (fully franked)  \n  - **Total FY25 dividend:** 24 cents per share (fully franked)  \n  - **Net Tangible Assets (NTA):** $8.33 per share (as of 30 June 2025)  \n  - **Share price:** $7.35 (trading at a discount to NTA)  \n\n- **Portfolio Performance:**  \n  - Portfolio return (including franking): **Disclosed but not explicitly stated in the extract** (refer to slide 13 for details).  \n  - Underperformance attributed to cyclical headwinds and lack of exposure to gold/insurance sectors.  \n\n- **Key Holdings:**  \n  - **Transurban:** Emphasis on inflation-linked tolls and dividend growth post-COVID.  \n  - **Fisher & Paykel Healthcare:** Strong earnings growth outlook in respiratory/surgical devices.  \n\n- **International Portfolio:**  \n  - Value: **$168.1 million** (1.6% of total portfolio).  \n  - FY25 return: **14.0%** (matched benchmark since inception).  \n\n- **Market Outlook:**  \n  - Cautious on earnings growth; valuation disparities noted (expensive growth vs. cheap value stocks).  \n  - Maintains balanced portfolio strategy.  \n\n- **No capital raising, material M&A, or changes to capital structure identified.**  \n- **Operational focus remains on long-term shareholder returns and stable dividends.**  \n\n*Note: Excluded non-material details (e.g., webcast logistics, disclaimer text).*",
  "usage": {
    "prompt_tokens": 2394,
    "completion_tokens": 345,
    "total_tokens": 2739,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T05:09:53.363532"
}